40 related articles for article (PubMed ID: 20647336)
1. Methyl selenocysteine: single-dose pharmacokinetics in men.
Marshall JR; Ip C; Romano K; Fetterly G; Fakih M; Jovanovic B; Perloff M; Crowell J; Davis W; French-Christy R; Dew A; Coomes M; Bergan R
Cancer Prev Res (Phila); 2011 Nov; 4(11):1938-44. PubMed ID: 21846796
[TBL] [Abstract][Full Text] [Related]
2. Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model.
Touma SE; Perner S; Rubin MA; Nanus DM; Gudas LJ
Biochem Pharmacol; 2009 Nov; 78(9):1127-38. PubMed ID: 19549509
[TBL] [Abstract][Full Text] [Related]
3. Methylseleninic acid induces NAD(P)H:quinone oxidoreductase-1 expression through activation of NF-E2-related factor 2 in Chang liver cells.
Park JM; Kim DH; Na HK; Surh YJ
Oncotarget; 2018 Jan; 9(3):3014-3028. PubMed ID: 29423025
[TBL] [Abstract][Full Text] [Related]
4. THE MAIN CYTOTOXIC EFFECTS OF METHYLSELENINIC ACID ON VARIOUS CANCER CELLS.
Varlamova EG; Turovsky EA
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205571
[TBL] [Abstract][Full Text] [Related]
5. Selective Impact of Selenium Compounds on Two Cytokine Storm Players.
Sinha I; Zhu J; Sinha R
J Pers Med; 2023 Sep; 13(10):. PubMed ID: 37888066
[TBL] [Abstract][Full Text] [Related]
6. Selenium in Prostate Cancer: Prevention, Progression, and Treatment.
Jiang J; Chen B; Tang B; Wei Q
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765058
[TBL] [Abstract][Full Text] [Related]
7. Effect of Dietary Methylseleninic Acid and Se-Methylselenocysteine on Carcinogen-Induced, Androgen-Promoted Prostate Carcinogenesis in Rats.
Bosland MC; Schlicht MJ; Deng Y; Lü J
Nutr Cancer; 2022; 74(10):3761-3768. PubMed ID: 35762420
[TBL] [Abstract][Full Text] [Related]
8. Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
Zhang J; Kim S; Li L; Kemp CJ; Jiang C; Lü J
Prostate; 2020 May; 80(7):588-605. PubMed ID: 32162714
[TBL] [Abstract][Full Text] [Related]
9. Comparative proteomic analysis of pepper (
Zhang C; Xu B; Geng W; Shen Y; Xuan D; Lai Q; Shen C; Jin C; Yu C
PeerJ; 2019; 7():e8020. PubMed ID: 31799069
[TBL] [Abstract][Full Text] [Related]
10. Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.
Lü J; Zhang J; Jiang C; Deng Y; Özten N; Bosland MC
Nutr Cancer; 2016; 68(1):1-17. PubMed ID: 26595411
[TBL] [Abstract][Full Text] [Related]
11. Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.
Bizzarro V; Belvedere R; Milone MR; Pucci B; Lombardi R; Bruzzese F; Popolo A; Parente L; Budillon A; Petrella A
Oncotarget; 2015 Sep; 6(28):25076-92. PubMed ID: 26312765
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas.
Zhang J; Wang L; Zhang Y; Li L; Tang S; Xing C; Kim SH; Jiang C; Lü J
Mol Carcinog; 2015 Dec; 54(12):1567-83. PubMed ID: 25307620
[TBL] [Abstract][Full Text] [Related]
13. Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer.
Christensen MJ; Quiner TE; Nakken HL; Lephart ED; Eggett DL; Urie PM
Prostate; 2013 Jun; 73(9):986-95. PubMed ID: 23389815
[TBL] [Abstract][Full Text] [Related]
14. Changes in proteomic profiles in different prostate lobes of male rats throughout growth and development and aging stages of the life span.
Das A; Bortner JD; Aliaga CA; Baker A; Stanley A; Stanley BA; Kaag M; Richie JP; El-Bayoumy K
Prostate; 2013 Mar; 73(4):363-75. PubMed ID: 22911278
[TBL] [Abstract][Full Text] [Related]
15. Lobe-specific proteome changes in the dorsal-lateral and ventral prostate of TRAMP mice versus wild-type mice.
Zhang J; Wang L; Zhang Y; Li L; Higgins L; Lü J
Proteomics; 2011 Jun; 11(12):2542-9. PubMed ID: 21598396
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.
Zhang J; Wang L; Anderson LB; Witthuhn B; Xu Y; Lü J
Cancer Prev Res (Phila); 2010 Aug; 3(8):994-1006. PubMed ID: 20647336
[TBL] [Abstract][Full Text] [Related]
17. Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit.
Wang L; Bonorden MJ; Li GX; Lee HJ; Hu H; Zhang Y; Liao JD; Cleary MP; Lü J
Cancer Prev Res (Phila); 2009 May; 2(5):484-95. PubMed ID: 19401524
[TBL] [Abstract][Full Text] [Related]
18. Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds.
Zhang J; Wang L; Li G; Anderson LB; Xu Y; Witthuhn B; Lü J
Nutr Cancer; 2011; 63(5):778-89. PubMed ID: 21614726
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
